IndraLab

Statements

CACNA1A inhibits serotonin. 1 / 1

| 1

sparser

"Three drugs have been approved by the FDA for the treatment of pain in FM: pregabalin, which binds to a voltage-dependent, presynaptic calcium channel, and duloxetine and milnacipran, which selectively inhibit reuptake of serotonin and norepinephrine, respectively."

26175876

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

CACNA1A inhibits serotonin. 1 / 1

INDRA sources:

Databases

Reading